RCE 3.03% 64.0¢ recce pharmaceuticals ltd

James pining his hopes for more cash ..... Taken from the last...

  1. 9,974 Posts.
    lightbulb Created with Sketch. 59
    James pining his hopes for more cash ..... Taken from the last Qtr.

    8.6.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?

    Answer: Yes. Further R&D rebates for FY2023 expected imminently. Significant R&D credits accrued since 1 July 2023 now backed by recently announced Australian Government Advanced Overseas R&D Finding awards a privileged position of future R&D repayment surety. It’s expected the Company will take advantage of this status by drawing down on R&D credits accumulated this FY via R&D advances.
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
64.0¢
Change
-0.020(3.03%)
Mkt cap ! $130.5M
Open High Low Value Volume
66.0¢ 66.0¢ 63.5¢ $29.44K 45.67K

Buyers (Bids)

No. Vol. Price($)
1 7736 64.0¢
 

Sellers (Offers)

Price($) Vol. No.
66.0¢ 33823 3
View Market Depth
Last trade - 15.48pm 02/05/2024 (20 minute delay) ?
Last
65.0¢
  Change
-0.020 ( 1.19 %)
Open High Low Volume
65.0¢ 65.0¢ 64.0¢ 16016
Last updated 15.59pm 02/05/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.